Vericel (FRA:ATQP) Machinery, Furniture, Equipment : €28.2 Mil (As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is Vericel Machinery, Furniture, Equipment?

Vericel's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2025 was €28.2 Mil.

Vericel's quarterly Machinery, Furniture, Equipment increased from Sep. 2024 (€15.8 Mil) to Dec. 2024 (€28.3 Mil) but then declined from Dec. 2024 (€28.3 Mil) to Mar. 2025 (€28.2 Mil).

Vericel's annual Machinery, Furniture, Equipment increased from Dec. 2022 (€14.1 Mil) to Dec. 2023 (€15.0 Mil) and increased from Dec. 2023 (€15.0 Mil) to Dec. 2024 (€28.3 Mil).

Vericel Machinery, Furniture, Equipment Historical Data

The historical data trend for Vericel's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vericel Machinery, Furniture, Equipment Chart

Vericel Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

9.31

12.25

14.14

15.05

28.26

Vericel Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															16.05	16.42	15.79	28.26	28.19

Vericel Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Vericel Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vericel Corp (FRA:ATQP) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

VCEL:USA

Address

64 Sidney Street, Cambridge, MA, USA, 02139

Website

https://www.vcel.com

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Vericel Headlines

No Headlines